| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Schentag JJ | |
| Moise PA | |||
| P921 | main subject | Staphylococcus aureus | Q188121 |
| vancomycin | Q424027 | ||
| P304 | page(s) | S31-4 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
| P1476 | title | Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections | |
| P478 | volume | 16 Suppl 1 |
| Q64240085 | Assessment of vancomycin utilization among Lebanese hospitals |
| Q34309620 | Comparative Efficacies of Human Simulated Exposures of Telavancin and Vancomycin against Methicillin-Resistant Staphylococcus aureus with a Range of Vancomycin MICs in a Murine Pneumonia Model |
| Q33790761 | Differences in hospital- and ventilator-associated pneumonia due to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between Europe and Latin America: a comparison of the EUVAP and LATINVAP study cohorts |
| Q35432686 | Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections |
| Q42948108 | Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus |
| Q41016957 | First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia |
| Q35214458 | In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus |
| Q41915074 | Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. |
| Q36961341 | Multicenter evaluation of vancomycin dosing: emphasis on obesity. |
| Q45127594 | Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections |
| Q37136539 | Rapidly fatal infections |
| Q36667211 | Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus |
| Q34783668 | Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia |
| Q35598459 | Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus |
| Q39386583 | Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients |
| Q36644897 | Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure. |
| Q35541702 | Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods |
| Q54392892 | Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem? |
| Q35879117 | Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia |
Search more.